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INTRODUCTION:  Desmoid  tumours  of  the  breast  are  rare.  Although  benign,  they can  mimic  breast  cancer
on  physical  examination,  mammography  and  breast  ultrasound  and  can  also  be locally  invasive.  Even
though  they  occur  sporadically,  they  can  also  be seen  as  a  part of Gardner’s  syndrome.  We  describe  a
case  of desmoid  tumour  in a woman  with  Gardner’s  syndrome  where  the  lesion  was mammographically
occult.
PRESENTATION  OF  CASE:  A 63-year  old  woman  presented  with  four  months  history  of  a  painful  left  breast
lump.  She  had  a screening  mammogram  seven  months  ago  which  was  normal.  She  is  known  to  have
Gardner’s  syndrome  and  had  a total  colectomy,  she  has  also  had  multiple  abdominal  desmoids  excised  in
the  past.  On examination  there  was  a 4  cm  ×  5 cm ﬁrm,  mobile  lump  in  the  left  breast.  Her  mammograms
in  the  clinic  were  also  normal.  Ultrasound  suggested  a benign  lesion  of  the  breast  and  a core  biopsy  showed
it  to be a benign  spindle  cell lesion.  She  underwent  wide  local  excision  of the  lump,  the intraoperative
mammograms  of  the  excised  specimen  also  failed  to detect  the  lesion.  Histopathology  of  the  excised
specimen  conﬁrmed  the  tumour  to be  a benign  desmoid  tumour.  She  has  now  been  offered  radiotherapy
and  nonsteriodal  anti-inﬂammatory  drugs  (NSAIDs)  to  reduce  her chances  of  a  local  recurrence.
CONCLUSION: A high  index  of  suspicion  and  a thorough  triple  examination  protocol  is  necessary  to detect
rare  lesions  like  a  desmoid  tumour  which  can  masquerade  as  breast  carcinoma.
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. . Introduction
Desmoid tumours (mammary ﬁbromatosis) arise most fre-
uently from the aponeurosis of the rectus abdominal muscle of
ultipara women.1 The extra-abdominal form is rare and desmoids
f the breast may  arise in the mammary gland or may  occur as an
xtension of a lesion arising from the muscles of the chest wall.1,2
y deﬁnition, ﬁbromatosis is non-encapsulated well-differentiated
broblastic lesion composed of relatively uniform ﬁbroblasts and
ollagen and forming a ﬁrm, solitary, or multinodular mass with
n inﬁltrative growth pattern. The incidence of mammary desmoid
umours is less than 0.2% of primary breast neoplasms.2,3 In Gard-
er’s syndrome the incidence ranges from 4% to 17%.4 Gardner’s
yndrome which was ﬁrst described in 1953 consists of adeno-
atous polyps of the gastrointestinal tract, desmoid tumours,
steomas, epidermoid cysts, lipomas, dental abnormalities and
eriampullary carcinomas.5 The incidence of the syndrome is
:14,025 with an equal sex distribution. It is determined by the
utosomal dominant familial polyposis coli gene on chromosome
.6 Mammography typically shows these tumours as spiculated
asses which can resemble malignancy.1,2,7 We  report a case of
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oi:10.1016/j.ijscr.2012.01.004
Open access under CC BYa desmoid tumour in a woman with Gardner’s syndrome wherein
the tumour was  mammographically occult.
2. Case report
A  63-year old Caucasian woman  presented to the breast clinic
with a four-month history of breast pain and a lump which she
noticed on standing up. She had breast pains in the past and was
also known to have breast cysts which were managed with aspira-
tion. Her last screening mammogram was  seven months ago which
was normal. She is known to have Gardner’s syndrome. In 1966
at the age of 20, she underwent subtotal colectomy and ileorectal
anastomosis for colonic polyposis and diagnosed to be belonging to
a  family of familial polyposis. A year later she underwent a laparo-
tomy, where a 10 cm desmoid involving the small bowel mesentery
was excised. She had a recurrence of the intra-abdominal desmoid
in 1978 which measured 15 cm ×7 cm and has been managed
expectantly since its diagnosis. She developed a desmoid tumour
in her laparotomy scar and this was  excised when she had a total
abdominal hysterectomy in 1990 for menorrhagia. She again devel-
oped a desmoid tumour on her abdominal wall which was excised
in 1992. The desmoid has since recurred and is now being managed
expectantly. She is on the familial polyposis registry and under-
goes regular surveillance gastroscopy and ﬂexible sigmoidoscopy.
Recent gastroscopy showed multiple duodenal and periampullary
-NC-ND license. 
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Fig. 2. Ultrasound breast.
Fig. 3. Desmoid tumour resected specimen.Fig. 1. Mammogram MLO.
olyps, which are being treated with argon ablation. Her mother
ad died of breast cancer at the age of 53.
Examination of the left breast showed a well deﬁned lump in
he lower outer quadrant measuring about 4 cm × 5 cm.  It was  ﬁrm
n consistency, mobile and not clinically attached to the skin or
nderlying muscle. The right breast, both axillae and both supra-
lavicular fossae were normal. Abdominal examination revealed a
arge 15 cm × 8 cm central abdominal mass and 3 cm × 4 cm ﬁrm
odular mass in her left paramedian abdominal operative scar.
ilateral mammograms showed a dense background with an area
f benign appearing microcalciﬁcation in the upper outer quad-
ant of her left breast (Fig. 1). This was away from the region of the
alpable lump. Ultrasound showed a patchy, hypoechoic area mea-
uring 30 mm × 45 mm in the lower outer quadrant of the left breast
Fig. 2). A core biopsy was then performed which showed the lesion
o be benign spindle cell lesion in keeping with a ﬁbromatosis of the
reast. Immunohistochemistry was performed on the core biopsy
pecimen which was negative for AE1/3, MNF, S100, CD34. It was
ositive for SMA  (smooth muscle actin), desmin and -catenin. The
pecimen was negative for oestrogen, progesterone and androgen
eceptors. A skull X-ray was obtained which was normal.
Due to her breast pain and discomfort, she wished to have the
eft breast lump excised. Intraoperatively, it was found to be inﬁl-
rating the pectoralis major muscle and was excised in toto along
ith the inﬁltrated portion of the pectoralis muscle (Fig. 3). An
ntraoperative mammogram of the specimen was performed which
id not demonstrate the lesion (Fig. 4). Her post operative period
as uneventful. Histopathology of the specimen conﬁrmed the
ndings of the core biopsy (Fig. 5). The lesion was  shown to be
 ﬁbromatosis with no cellular atypia, all margins except the pos-
erior margin were clear. The posterior margin showed inﬁltration Fig. 4. Intraoperative mammogram.
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f the tumour into the muscle ﬁbres, following a discussion in our
ulti disciplinary team (MDT) meeting she has now been offered
adiotherapy and NSAIDs to reduce her likelihood of a recurrence.
. Discussion
The emergence of our understanding of the systemic nature of
ardner’s syndrome is well demonstrated in the protracted clin-
cal history of this patient. She initially presented at the age of
wenty with polyposis of the colon and had a subtotal colectomy,
his was followed by recurrent intra-abdominal and abdominal wall
esmoid tumours. More recently, apart from her breast lump she
as developed polyps in the duodenum. This type of progressive
ulti-system involvement is classical of Gardner’s syndrome.5
Desmoid tumours associated with Gardner’s syndrome have
een shown to have an alteration of the -catenin pathway and
ver express -catenin, as was seen in our patient.8 Fibromatoses
ssociated with polyposis are usually noted in the colectomy scar,
esions may  also be encountered in the small bowel mesentery,
s dense intraabdominal adhesions, and very rarely in extra-
bdominal sites.4,5
Our patient presented with mastalgia and a painful lump.
ost reports in literature suggest otherwise, with the tumour
eing a painless, lump that mimics a carcinoma on clinical
xamination.1–3,10 Mammography typically show a high density,
piculated, stellate tumour without microcalciﬁcations often indis-
inguishable from carcinoma.1,2,7 This was in contrast to the
ammographic ﬁndings we noted in our patient, this lesion was
ot picked up by screening, preoperative and postoperative speci-
en  mammograms.
On ultrasound scan, desmoid tumours are frequently poorly
arginated, hypoechoic masses with a thick echogenic rim and
osterior attenuation.3,7 Fine needle aspiration cytology or prefer-
bly core biopsy, although not entirely speciﬁc, may  lead to a
iagnosis of breast ﬁbromatosis and is useful in planning a sur-
ical approach to the lesion. The degree of cellularity can vary with
ngerlike extensions extending at the periphery of the lesion into
djacent breast parenchyma.1,2,9 The histopathologic differential
iagnosis can vary from benign reactive lesions such as a hyper-
roliferative scar, to a more sinister ﬁbrosarcoma.9
Due to the unapparent extensions of these lesions into adjoin-
ng tissues, wide local excision is the recommended treatment. A
ecurrence rate ranging from 21 to 57% has been noted with surgical
reatment alone.1–3,12 Margin status, large tumour size and young
ge have been associated with a higher incidence of recurrence.2,12
s breast ﬁbromatosis do not demonstrate metastatic capabilities,PEN  ACCESS
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axillary dissection is not performed. A routine quarterly clinical
examination is advised for a minimum of three years as the majority
of local recurrences manifest within this time frame.2,12,13
The high recurrence rate associated with surgical resection of
extra-abdominal desmoid tumours has resulted in a number of
adjuvant therapies being explored.2,12–15 Even though there is con-
ﬂicting evidence in literature, radiation therapy is often employed
to improve local control rates and has been shown in one systematic
review to improve local control when used alone or in combination
with surgery, when compared with surgery alone.12 Postoperative
radiation therapy can improve the 10-year recurrence-free sur-
vival rate.14 The current options for pharmacological treatment
of desmoid tumours range from NSAIDs to hormonal agents to
cytotoxic therapy, but the mechanisms by which most of these
agents affect desmoid tumours are not entirely clear. NSAIDs,
most commonly Indomethacin and Sulindac, have been associated
with partial responses or even complete resolution of desmoid
tumours.2,13,15 Extramammary desmoid tumours are usually pos-
itive for oestrogen and progesterone receptors, and therefore a
role for hormonal therapy has been proposed.11 Hormonal agents
(Tamoxifen and Toremifene) have shown response rates of 30–50%
over one year.16 Mammary desmoids especially those associated
with polyposis syndromes are characteristically negative for hor-
mone receptors as was  observed in this case and hence our patient
was not offered any hormonal therapy.11 An interesting study by
Ishizuka et al. has shown Tamoxifen to be effective even in oestro-
gen receptor (ER) negative breast desmoid tumours, this may  partly
be explained by the fact that Tamoxifen induces the synthesis of
transforming growth factor beta 1 (TGF1) by ER-negative ﬁbrob-
lasts, which can cause apoptosis and regression of the tumour.11 A
variety of cytotoxic therapies have been used with no clear superi-
ority of any one regimen.2
4. Conclusion
Desmoid tumour of the breast may present a difﬁculty in the
diagnosis especially where imaging studies are not conclusive and
suggest a more ominous diagnosis. A biopsy is always indicated as
the deﬁnitive method to determine nature of the tumour. Manage-
ment of these lesions is complex, the main problem being the high
rates of recurrence. Wide surgical resection with clear margins is
the most widely practiced technique with radiation, chemotherapy,
or hormonal therapy being used to reduce recurrence rates.
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